Analysts at Berenberg upped their target price on bakery chain Greggs from 1,600p to 1,780p, on Monday, praising the group for its "excellent start" to the year.
Thomas Cook was under the cosh again on Friday a day after its shares tumbled on the back of a profit warning, as Citi downgraded it to 'sell' from 'neutral', arguing that the stock is basically worthless.
Berenberg started coverage of "outstanding" Spirax-Sarco Engineering at 'buy' on Thursday as it took a look at the capital goods and industrial engineering sector.
The outlook for revenue growth is the main question hanging over Vodafone after the company cut its dividend, Credit Suisse analysts said as they lowered their price target.
JP Morgan analyst Raul Sinha reiterated his 'underweight' stance on shares of HSBC, telling clients that the lender's valuation had yet to reflect the risk to revenues from trade concerns.
Citi upgraded its recommendation on Marks & Spencer shares to buy' from 'neutral' on Monday, as it argued that the investment case is "evolving".
Citi downgraded its stance on shares of Auto Trader to ‘neutral’ from ‘buy’ on Friday as it said the risk/reward is now more balanced.
Analysts at Canaccord Genuity upped their target price on builders' merchant Travis Perkins on Thursday, stating the firm's good start to the year justified its recent re-rating.
Berenberg lowered its target for Sirius Minerals' share price from 40p to 35p after incorporating the structure of the potash miner's long-awaited stage two financing for its Woodsmith polyhalite mine into its valuation model.
Berenberg slashed its target price for shares of NMC Health after rebasing its model and transferring coverage to analyst Michael Ruzic-Gaithier, but continued to see significant upside.
ShoreCap stuck to its previous 'buy' recommendation for Lloyds' shares, despite the lender having fallen short of the broker's estimates for its first-quarter net interest income.
Morgan Stanley has highlighted a range of strategies BT’s newly installed chief executive could unveil next week, including spinning out Openreach, but has warned there is a real chance that there will be no significant changes to the strategy announced at the full-year results.
UBS downgraded investment manager Jupiter Fund Management from 'neutral' to 'sell' on Thursday, citing the group's strong share price performance over the past month and a change in portfolio manager at two key European equity funds as its reasons.
Jefferies initiated coverage on shares of car retailer Inchcape at 'buy' with an 845p price target on Tuesday, arguing that the "undervalued" distributor could drive upgrades by applying material surplus cash flow to M&A or share buybacks.
Analysts at Deutsche Bank reiterated their 'buy' rating and 6,900p target price on British-Swedish pharmaceutical outfit AstraZeneca on Monday.
Bus and rail operator Stagecoach got a boost on Friday as Citi upped its stance on the shares to 'buy' from 'neutral' as it argued there is too much negative sentiment priced in.
Peel Hunt slashed its price target on shares of over-50s specialist Saga to 110p from 180p on Thursday as it cuts its earnings per share estimates to account for pricing cuts and the company's investment in growing the customer base.
JPMorgan Cazenove downgraded its stance on Anglo American to 'neutral' on Wednesday, exiting its three-year conviction 'overweight' on the stock as it highlighted three reasons for the move and recommended a tactical short of Anglo versus longing Glencore into first-half results in July/August.
Shares in builders' merchant Travis Perkins got a boost on Tuesday as Bank of America Merrill Lynch double-upgraded it to 'buy' from 'underperform' and hiked its price target to 1,700p from 1,000p, pointing to upside from an improving volume backdrop, asset disposals and a new chief executive.